ArticleJournal for immunotherapy of cancer2024

TCF1-positive and TCF1-negative TRM CD8 T cell subsets and cDC1s orchestrate melanoma protection and immunotherapy response.

Saraí G De León-Rodríguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.